Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CARD14 encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Additionally we are shipping CARD14 Proteins (6) and and many more products for this protein.
Showing 10 out of 59 products:
Human Polyclonal CARD14 Primary Antibody for WB - ABIN528893
Huh, Kim, Kim, Song, Jung, Jeong, Lee, Kim, Lee, An: Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. in British journal of cancer 2013
Results identified RNF7 (show RNF7 Antibodies) to interact with CARMA2 regulating its NF-kappaB (show NFKB1 Antibodies)-activating capacity. Mechanistically, RNF7 (show RNF7 Antibodies) influences CARMA2 signaling by regulating the ubiquitination state of MALT1 (show MALT1 Antibodies) and the NF-kappaB (show NFKB1 Antibodies)-regulatory molecule NEMO (show IKBKG Antibodies). Interestingly, CARMA2short (CARMA2sh) mutants associated with psoriasis susceptibility escape the negative control exerted by RNF7 (show RNF7 Antibodies).
The serine/threonine kinase (show TLK2 Antibodies) ULK2 (show ULK2 Antibodies) binds to and phosphorylates CARMA2sh.
MALT1 (show MALT1 Antibodies) deficiency or pharmacological inhibition of MALT1 (show MALT1 Antibodies) catalytic activity inhibits pathogenic mutant CARD14-induced cytokine and chemokine (show CCL1 Antibodies) expression in human primary keratinocytes.
CARD14/MALT1 (show MALT1 Antibodies)-mediated signaling in keratinocytes has a role in psoriasis [review]
The results indicate that the common CARD14 p.Arg820Trp variant might have a significant effect on the response to anti-TNF (show TNF Antibodies) therapies among patients with psoriasis. In addition, rare CARD14 missense variants could also predispose to a better response.
Our findings, combined with the published literature, suggest that Pityriasis Rubra Pilaris Type V, both familial and sporadic, can be caused by CARD14 mutations.
Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10 (show BCL10 Antibodies)-MALT1 (show MALT1 Antibodies)-dependent NF-kappaB (show NFKB1 Antibodies) activation
genetic evidence suggests association of the CARD14 single nucleotide polymorphism rs11652075 and other rare mutations in this gene with psoriasis. To assess whether combined data support the relationship between CARD14 rs11652075 and susceptibility to this disease, we conducted a meta-analysis. Our results demonstrate a significant association between the CARD14 rs11652075 polymorphism and psoriasis.
The authors observations provide further insights into the genetics of psoriasis and functional information on novel CARD14 mutational variants seen in cases from Tunisia and other populations.
Genetic interactions of SNPs in CARD14, SENP1 (show SENP1 Antibodies) and VEGFA (show VEGFA Antibodies) might represent a functional mechanism in the pathogenesis of high altitude polycythemia.
in experimental models of psoriasis induced by either imiquimod cream or recombinant IL-23 (show IL23A Antibodies) injection, the psoriasiform skin inflammation was abrogated in Card14(-/-) mice
This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants.
CARD-containing MAGUK protein 2
, bcl10-interacting maguk protein 2
, card-maguk protein 2
, carma 2
, caspase recruitment domain-containing protein 14
, bcl10-interacting MAGUK protein 2